Published by Josh White on 27th August 2025
(Sharecast News) - Crystal Amber said on Wednesday that its portfolio company Morphic Medical has secured commercial registration from the UK Medicines and Healthcare products Regulatory Agency for its 'RESET' endoscopic treatment for obesity and type 2 diabetes, paving the way for UK sales.